Regenxbio Inc at JPMorgan Healthcare Conference Transcript
All right. Good morning, everyone, and welcome to day 2 of the 41st Annual JPMorgan Healthcare Conference. My name is Dave Praharaj, and I'm an associate with the JPM Healthcare Group. Today, I have the pleasure of introducing REGENXBIO, along with their President and CEO, Ken Mills, who will be giving the presentation.
After the presentation, there will be some time for Q&A. So thank you, and take it away, Ken.
Thank you, Dave. Thanks to the JPMorgan organizers. I especially want to acknowledge [John Whittaker,] on the banking team, who's always a strong advocate for REGENXBIO at this conference and in general. Making reference here to the fact that I probably will make some forward-looking statements during the presentation today and additional information about any statements I may make or information to back them up can be found in our SEC Regulatory filings.
So I'm going to start the presentation out today with just a quick story. I have a colleague, a colleague
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
